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ABSTRACT 24 
 25 
Shiga toxin (Stx)-producing, food-contaminating Escherichia coli (STEC) is a major 26 
health concern.  Plant-derived pectin and pectic-oligosaccharides (POS) have been 27 
considered as prebiotics and for the protection of humans from Stx.  Of five structurally 28 
different citrus pectic samples, POS1, POS2 and modified citrus pectin 1 (MCP1) were 29 
bifidogenic with similar fermentabilities in human faecal cultures and arabinose-rich 30 
POS2 had the greatest prebiotic potential.  Pectic oligosaccharides also enhanced 31 
lactobacilli growth during mixed batch faecal fermentation. We demonstrated that all 32 
pectic substrates were anti-adhesive for E. coli O157:H7 binding to human HT29 cells.  33 
Lower molecular weight and deesterification enhanced the anti-adhesive activity.  We 34 
showed that all pectic samples reduced Stx2 cytotoxicity in HT29 cells, as measured by 35 
the reduction of human rRNA depurination detected by our novel TaqMan-based RT-36 
qPCR assay, with POS1 performing the best.  POS1 competes with Stx2 binding to the 37 
Gb3 receptor based on ELISA results, underlining the POS anti-STEC properties.           38 
 39 
 40 
 41 
Keywords:  42 
STEC; orange pectic oligosaccharides; anti-adhesion; Shiga toxin 2; TaqMan RT-qPCR; 43 
rRNA depurination; HT29 cells 44 
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1. Introduction 46 
Shiga toxin (Stx)-producing Escherichia coli (STEC) is a major health concern 47 
due to the debilitating hemolytic uremic syndrome which can occur when STEC-48 
contaminated food is ingested.  The Stx holotoxin consists of A and B subunits (Di, Kyu, 49 
Shete, Saidasan, Kahn, & Tumer, 2011).  The doughnut-like structure formed by five of 50 
the Stx 7.7 kDa B-subunits binds to the neutral glycolipid globotriaosylceramide  (Gb3) 51 
receptor terminated by α-Gal-(1-4)-ß-Gal on the human intestinal epithelial cell surface 52 
(Jacewicz, Clausen, Nudelman, Donohue-Rolfe, & Keusch, 1986).  The interaction 53 
between Stx B pentamer and Gb3 results in the internalization of the Stx holotoxin by 54 
clathrin-mediated endocytosis (Sandvig, Grimmer, Lauvrak, Torgersen, Skretting, van 55 
Deurs, et al., 2002).  The Stx A subunit is a glycosidase belonging to the ribosome-56 
inactivating protein family that is capable of removing a specific adenine (depurination) 57 
in the conserved sarcin ricin loop (SRL) of the large 28S rRNA of mammalian cells, 58 
resulting in translation inhibition and cell death (Di, Kyu, Shete, Saidasan, Kahn, & 59 
Tumer, 2011).  It is estimated by the Center for Disease Control that STEC O157:H7 60 
causes more than 96,000 cases of diarrheal illness and 3,200 hospitalizations annually in 61 
the United States (Scallan, Hoekstra, ANgulo, Tauxe, Widdowson, Roy, et al., 2011).  62 
Presently there is no effective treatment for STEC-related food poisoning.  There is 63 
considerable interest in developing dietary approaches to control food-contaminating 64 
pathogens.   65 
 Pectic oligosaccharides (POS) have potential as food ingredients that can control 66 
STEC pathogens.  Plant-derived pectin and POS have attracted particular attention as 67 
they are abundant in biomass.  Pectin consists of a galacturonic acid-rich backbone, 68 
  
4 
 
known as homogalacturonan, that is partially methyl-esterified.  Rhamnose residues 69 
interrupt the homogalacturonan to form rhamnogalacturonan I (RG I) and are the branch 70 
points for arabino-, galacto- and arabinogalacto-oligosaccharides.  POS is obtained from 71 
pectin by enzymatic treatment and acid hydrolysis.   POS from high methoxylated citrus 72 
pectin and from low methoxylated apple pectin protected human colonic HT29 cells from 73 
the toxic effects of E. coli O157:H7 Stx1 and Stx2 at 10 mg/ml (Olano-Martin, Williams, 74 
Gibson, & Rastall, 2003).  However, the protective mechanism was not elucidated.  75 
Later, Rhoades, Manderson, Wells, Hotchkiss, Gibson, Formentin, et al. (2008) 76 
enumerated viable, attached STEC on HT29 cells and showed that POS provided 70% 77 
protection by inhibiting the adhesion of STEC at 2.5 mg/ml compared to non-POS-78 
treated cells.  These authors also found that the POS could reduce the cytotoxicity of Stx1 79 
and Stx2 at concentrations of 0.01 to 1 g/ml, respectively.  However, the mechanism of 80 
activity was unclear since the POS did not contain α-Gal-(1-4)-ß-Gal. 81 
POS are known for their prebiotic potential in vitro.  The same POS that protected 82 
human colonic HT29 cells from the toxic effects of E. coli O157:H7 Stx1 and Stx2 was 83 
also bifidogenic (Olano-Martin, Gibson, & Rastell, 2002).  POS from a variety of sources 84 
was bifidogenic if it contained arabino- and/or galacto-oligosaccharide side chains 85 
(Manderson, Pinart, Tuohy, Grace, Hotchkiss, Widmer, et al., 2005; Onumpai, Kolida, 86 
Bonnin, & Rastall, 2011).  While Guggenbichler, De Bettignies-Dutz, Meissner, 87 
Schellmoser, & Jurenitsch (1997) originally reported that galacturonic acid disaccharides 88 
and trisaccharides had E. coli anti-adhesive activity, it remains unclear which pectic 89 
oligosaccharide structures are responsible, due to the diversity of pectic fractions reported 90 
to have this activity.   91 
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 In previous studies, the cytotoxicity of Stx was measured as a function of neutral 92 
red uptake by the viable cells in the treated samples compared to the non-treated control 93 
sample.  Molecular methods have been used to accurately measure the degree of rRNA 94 
damage from Stx depurination.  The first such method is called dual primer extension, 95 
using two radioactively labelled oligo DNA primers to measure the levels of the broken 96 
rRNA and the total rRNA, respectively, in a single reverse transcription reaction (Di, 97 
Kyu, Shete, Saidasan, Kahn, & Tumer, 2011).  Recently, a real-time RT-qPCR (reverse 98 
transcription-quantitative polymerase chain reaction) method with SYBR Green mix was 99 
developed to quantify the depurinated rRNA level in total RNA, based on the fact that 100 
reverse transcriptase usually incorporates an adenosine opposite to the abasic site on the 101 
template strand (Melchior & Tolleson, 2010).  Thus, a T → A transversion is created 102 
when cDNA is synthesized by reverse transcriptase, using depurinated rRNA as the 103 
template.  For this RT-qPCR depurination assay, two sets of primers are designed: one set 104 
close to the depurination site to measure total 28S rRNA and the other set to detect the 105 
altered sequence at the depurination site.  Use of RT-qPCR to measure the level of 106 
depurinated rRNA among total RNA has greatly improved the accuracy of quantification.  107 
It has also saved time and obviated the use of radioactive materials.  The RT-qPCR with 108 
SYBR Green method has been used to measure rRNA depurination caused by ricin and 109 
Stx (Melchior & Tolleson, 2010; Pierce, Kahn, Chiou, & Tumer, 2011).  110 
 In this study, we analyzed the carbohydrate structures of five different POSs from 111 
orange peel, compared their bifidogenic potentials and investigated their inhibitory 112 
effects on the adhesion of E. coli O157:H7 (ATCC43895) bacteria to HT29 cells.  In 113 
addition, to study the inhibitory effect of POS on Stx cytotoxicity, we developed a novel 114 
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RT-qPCR method, using TaqMan probes to quantify the level of depurinated rRNA 115 
versus total rRNA as a measurement of Stx2 cytotoxicity in HT29 cells.  TaqMan-based 116 
qPCR is practised for its higher specificity and sensitivity than SYBR Green-based 117 
qPCR.  The TaqMan qPCR genotyping approach has been used to detect single 118 
nucleotide polymorphism (SNP) (Kamau, Alemayehu, Feghali, Tolbert, Ogutu, & 119 
Ockenhouse, 2012).  As a T → A transversion is created when cDNA is synthesized 120 
using the depurinated RNA as a template, the cDNA population containing the T → A 121 
mutation can be considered as a cDNA with a single SNP.  Our results show that the 122 
rRNA depurination resulting from Stx2 cytotoxicity can be sensitively measured by our 123 
TaqMan RT-qPCR method.  We demonstrate the POS structures that are optimal for 124 
bifidogenic properties, inhibition of the adhesion of ATCC43895 to HT29 cells and 125 
reduction of the cytotoxicity of Stx2 in HT29 cells.   126 
 127 
2. Materials and methods 128 
 129 
2.1. POS  130 
 131 
Orange peel POS (OpPOS) was prepared by pilot plant-scale acid hydrolysis of 132 
orange peel, according to Manderson, et al. (2005).  The pectin was precipitated from the 133 
hydrolysate with isopropyl alcohol and removed by filtration.  The filtrate containing 134 
OpPOS was desalted by 1,000 molecular weight cutoff nano-filtration. The OpPOS used 135 
here was a different batch produced at the same time as the material used by Manderson, 136 
et al. (2005).  The differences in monosaccharide composition  between the OpPOS 137 
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batches were minor other than 8 × less glucose and 2 × more galacturonic acid in the 138 
OpPOS used here (Table 1) compared to that used previously (Manderson, et al., 2005).  139 
Pectic Oligosaccharide I (POS1), Pectic Oligosaccharide II (POS2), Modified Citrus 140 
Pectin I (MCP1) and Modified Citrus Pectin II (MCP2) were obtained from 141 
EcoNugenics, Inc. (Santa Rosa, CA, USA).  The POS and MCP samples were produced 142 
by enzymatic treatment of citrus peel or commercial pectin.   143 
 144 
2.2. Carbohydrate analysis 145 
 146 
The POS and MCP monosaccharide composition was analyzed, following 147 
methanolysis (Manderson, et al., 2005), by high-performance anion-exchange 148 
chromatography with pulsed amperometric detection (HPAEC-PAD), using a DX-500 149 
(Dionex, Sunnyvale, CA, USA) system and a CarboPac PA-20 column operated at 0.5 150 
ml/min, as described previously (Hotchkiss, Nunez, Strahan, Chau, White, Marais, et al., 151 
2015).   The HPAEC-PAD mobile phase consisted of 14 mM NaOH for 13 min, followed 152 
by a 0–120 mM CH3COONa gradient in 100 mM NaOH for 17 min and it was returned 153 
to 14 mM NaOH for 40 min prior to the next injection.  Molecular weight (MW) was 154 
determined by high pressure size exclusion chromatography (HPSEC), with three TSKgel 155 
GMPWXL (Tosoh Bioscience, Tokyo, Japan) columns and four detectors (HELEOS II 156 
multi-angle laser light scattering, refractive index, 255-V2 differential pressure 157 
viscometer; Wyatt Technology, Santa Barbara, CA, USA) and a UV-1260 Infinity 158 
spectrophotometer (Agilient Technologies, Santa Clara, CA, USA), as reported 159 
previously (Qi, Chau, Fishman, Wickham, & Hotchkiss, 2014).  MW values reported are 160 
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weight average molar mass values.  The degree of methyl esterification was determined 161 
as described previously (Fishman, Chau, Cooke, & Hotchkiss, 2008). 162 
 163 
2.3. In vitro batch fermentation  164 
 165 
Basal medium ingredients (per litre) were: 2.0 g peptone water, 2.0 g yeast 166 
extract, 0.1 g NaCl, 0.04 g K2HPO4, 0.04 g KH2PO4, 0.01 g MgSO4.7H2O, 0.01 g 167 
CaCl2.6H2O, 2.0 g NaHCO3, 2 ml Tween 80, 0.05 g haemin, 10 µl vitamin K1, 0.5 g L- 168 
cysteine HCl, 0.5 g bile salts and 4 ml resazurin (0.05 g/l).  Medium was sterilized at 120 169 
o
C for 20 min before aseptically dispensing into the sterile fermenters.  Substrates were 170 
used at 1% (w/v) as the sole carbon source.  Inulin ST (Beneo-Orafti, Tienen, Belgium) 171 
was used as a positive control.  Faecal samples from five healthy adults (3 male, 2 172 
female, mean age of 30.0±7.2 years old) who had not consumed prebiotic or probiotic 173 
products, nor had received antibiotic treatment within 3 months before study were 174 
obtained in situ in the Department of Food and Nutritional Sciences, The University of 175 
Reading.  Samples were kept in an anaerobic cabinet and processed within 10 min.  176 
Faecal slurries (10% w/w) in 0.17 M phosphate-buffered saline (PBS), pH 7.3 (Oxoid, 177 
Basingstoke, UK) were prepared and were homogenized in a stomacher (Stomacher 400, 178 
Seward, UK) at normal speed for 2 min.  The inoculum size was 10% v/v.  pH was 179 
regulated at 6.80±0.10 with a pH controller (Fermac 260, Electrolab, Tewkesbury, UK).  180 
Fermentation samples were taken at 0, 10, 24, 36 and 48 h.  Samples were analyzed for 181 
bacterial populations and concentration of short chain fatty acids (SCFA).  All 182 
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experiments were performed in compliance with the laws and guidelines at the University 183 
of Reading, UK.   184 
 185 
2.4. SCFA analysis by HPLC  186 
 187 
The samples from batch cultures were centrifuged at 13,000 g for 10 min to 188 
obtain the supernatant.  The clear solution was kept at -20 
o
C prior to further analysis.  189 
Before analysis by HPLC, the samples were centrifuged at 13,000 g for 10 min.  The 190 
supernatant was filtered through 0.2 m pore size syringe filters (Millipore, UK).  The 191 
column was an ion-exclusion REZEX-ROA organic acid column (300 × 7.80 mm; 192 
Phenomenex, Cheshire, UK) maintained at 84 °C.  The eluent was 0.0025 mM H2SO4, 193 
flow rate of 0.6 ml/min.  Concentrations of the separated organic acids were calculated 194 
from calibration curves of acetic, propionic, butyric, formic and lactic acids at 195 
concentrations of 6.25 to 120 mM, and results were expressed in mmol/ml. 196 
 197 
2.5. Bacterial enumeration by fluorescence in situ hybridization (FISH)  198 
 199 
Enumeration of the target faecal bacteria groups was achieved by FISH with 200 
fluorescently labelled 16S rRNA probes according to the method described by Vulevic, 201 
Drakoularakou, Yaqoob, Tzortzis, & Gibson (2008).  The 16S rRNA-targetted 202 
oligonucleotide probes used were Lab158 (Harmsen, Elfferich, & Schut, 1999), Bif164 203 
(Langendijk, Schut, Jansen, Raangs, Kamphuis, Wilkinson, et al., 1995), Bac303 (Manz, 204 
Amann, Ludwig, Vancanneyt, & Schleifer, 1996), Erec482 (Franks, Harmsen, Raangs, 205 
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Jansen, Schut, & Welling, 1998), Chis150 (Franks, Harmsen, Raangs, Jansen, Schut, & 206 
Welling, 1998) and Ato291 (Harmsen, Wildeboer-Veloo, Grijpstra, Knol, Degener, & 207 
Welling, 2000) for the group of Lactobacillus/Enterococcus, Bifidobacterium, 208 
Bacteroides/Prevotella, Clostridium coccoides–Eubacterium rectale, Clostridium 209 
histolyticum and Atopobium cluster, respectively.  The probe-hybridized bacterial cells 210 
were counted at 565 nm, using fluorescence microscopy.  A total bacterial count was 211 
obtained by staining with 4’6-diamidino-2-phenylindole (DAPI).  Bacterial cells were 212 
counted at 461 nm, using UV light for excitation.  A minimum of 15 fields of view were 213 
counted for each sample.  The number of cells obtained is expressed as log10 cells/ml.  214 
Statistical analysis was performed using SPSS for Windows, version 17.0. One-215 
way analysis of variance (ANOVA) and Tukey’s posthoc test were used to determine 216 
significant differences among the bacterial group populations and SCFA concentrations 217 
among the different substrates.  A paired independent t-test was also used to determine 218 
significant changes for each bacterial group concentration at inoculation and subsequent 219 
sampling point.  Differences were considered to be significant when p<0.05. 220 
  221 
2.6. Microbiological media and chemicals  222 
 223 
 Pre-formulated, dehydrated tryptic soy agar medium and the following chemicals 224 
were purchased from Sigma Aldrich (St. Louis, MO, USA) and prepared according to the 225 
manufacturer’s instructions: PBS tablets (pH ± 0.2, 0.1 mol/l), non-essential amino acid 226 
solution, trypsin-EDTA solution and Dulbecco’s modified Eagle medium with 227 
GlutaMAX-1 (DMEM).  PBS was prepared according to the manufacturer’s instructions 228 
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and filter-sterilized with a 0.2 µm syringe filter.  Faetal bovine serum (FBS) was obtained 229 
from American Type Culture Collection (ATCC, Manassas, VA, USA).   230 
 231 
2.7. Bacterial cultures  232 
 233 
 Working cultures of E. coli O157:H7 strain ATCC43895 (ATCC, Manassas, VA, 234 
USA) were prepared by inoculating the bacteria on a count agar plate and incubating the 235 
plate for 18-24 h at 37 ºC.  E. coli broth cultures for adhesion assays were grown in 236 
DMEM supplemented with 5% (v/v) FBS and 1% (v/v) nonessential amino acid solution 237 
(SDMEM) and incubated at 37 
o
C for 18-24 h.  The overnight culture was then inoculated 238 
1% (v/v) into fresh SDMEM and incubated for a further 18-24 h under the same 239 
conditions.  On the day of the assay, a 10% (v/v) inoculum was again inoculated into pre-240 
warmed SDMEM and incubated for 4 h at 37 ºC. 241 
  242 
2.8. Cell cultures  243 
 244 
 HT29 human colon adenocarcinoma epithelial cells were obtained from ATCC 245 
(Manassas, VA, USA) and cultured in DMEM supplemented with 5% FBS and 1% 246 
SDMEM, plus 20 units/ml of penicillin, and 20 g/ml of streptomycin at 37 oC with 5% 247 
CO2.  Cells were grown in 25-cm
2
 tissue culture flasks until reaching confluence, split 248 
according to the European Collection of Cell Cultures-recommended method and stored 249 
in aliquots in liquid nitrogen.  These aliquots were used to seed 25 cm
2
 flasks which, after 250 
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growth, were split into 12-well tissue culture plates.  Cells were grown to confluence 251 
before being used for the adhesion assays. 252 
 253 
2.9. Bacterial adhesion assay  254 
 255 
 Adhesion assays with the E. coli strains were carried out as follows:  a culture of 256 
the test strain was prepared as described above, and then diluted 1:500 in PBS.  The 257 
viable count of the diluted suspension was determined by spread-plating onto plate count 258 
agar, with decimal dilution being carried out in PBS buffer as appropriate.  POSs were 259 
dissolved in PBS (5 mg/ml) and sterilized by passing through a 0.2 µm syringe filter.  260 
The carbohydrate solutions were further diluted in sterile PBS as required.  The SDMEM 261 
was aspirated into a 12-well tissue culture plate with near confluent monolayers of HT29 262 
cells, prepared as described above.  The monolayers were washed by pipetting in 1 ml of 263 
sterile PBS per well, swirling by hand, and then aspirating.  A 0.5 ml aliquot of POS 264 
solution was added to the well, followed by 0.5 ml of bacterial suspension in PBS.  Un-265 
supplemented PBS was substituted for POS solution in the control well.  All assays were 266 
performed in triplicates.  The plates were swirled by hand to mix and incubated at 37 ºC 267 
for 2 h. 268 
 After incubation, the bacterial suspension was aspirated from the wells.  A 1 ml 269 
aliquot of PBS was added to each well, the plate was swirled briefly by hand, and the 270 
PBS was removed.  The washing step was repeated two more times.  A 70 µl aliquot of 271 
trypsin-EDTA solution was added to each well, the plate was rocked to ensure even 272 
coverage, and then it was incubated at 37 ºC for 5 min.  A 1 ml aliquot of PBS was then 273 
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pipetted into each well and pipette-mixed until the monolayer was completely dislodged 274 
and clumps dissolved, as determined visually.  Bacteria in cell suspension were then 275 
enumerated by plate-counting on count agar plates with decimal dilutions performed in 276 
PBS as required.  All plates were incubated at 37 ºC for 18-24 h before colonies were 277 
enumerated.  Viable counts were calculated for all wells and are expressed as CFU 278 
(colony forming unit)/ml.  The anti-adhesion activity of POS was assessed as the 279 
percentage of viable counts in the POS-treated samples compared to the untreated 280 
samples.  For each test, the mean and the standard error of the triplicate wells were 281 
calculated.  Statistical significances were determined by one-way analysis of variance, 282 
using ANOVA software. 283 
 284 
2.10. Cytotoxicity of Stx2 in HT29 cells   285 
 286 
 Stx2 holotoxin was acquired from BEI Resources (Manassas, VA).  HT29 cells 287 
grown to 90% confluence were treated with 5 ng of Stx2 in 100 l SDMEMper well 288 
(final Stx2 concentration was 50 ng/ml) in the 96-well plate for 24 h (Pang, Park, Wang, 289 
Vummenthala, Mishra, McLaughlin, et al., 2011).  To isolate total RNA from treated and 290 
untreated HT29 cells, the RLT lysis buffer from the RNeasy Mini Kit (Qiagen, Valencia, 291 
CA, USA) was added directly to each well after the medium was aspirated.  Total cell 292 
RNA was extracted following the manufacturer’s protocol and quantitated by a 293 
NanoDrop spectrophotometer (Thermo Fisher, Waltham, MA, USA). 294 
 295 
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2.11. Dual primer extension assay to measure rRNA depurination due to Stx2 cytotoxicity 296 
in HT29 cells   297 
 298 
 The dual primer extension method has been used extensively to determine the 299 
levels of rRNA depurination caused by Stx (Di, Kyu, Shete, Saidasan, Kahn, & Tumer, 300 
2011) and ricin from Ricinus communis (castor bean) (Li, Baricevic, Saidasan, & Tumer, 301 
2007).  In brief, a primer (P1, 28S) was designed to anneal to the 5’ end of human 28S 302 
rRNA (GenBank accession # NR_003287) and would produce a 99-base single-stranded 303 
(ss) cDNA in a RT (reverse transcription) reaction.  Another primer (P2, Dep) was 304 
designed to anneal just upstream of the depurination site in the sarcin ricin loop (SRL) of 305 
28S rRNA, resulting in a 72-base ss cDNA RT product if 28S rRNA was depurinated 306 
(Fig. 1).  Both the 28S and Dep primers were end-labelled with 
32
P-ATP by T4 kinase 307 
and used together in an RT reaction by Superscript II (Life Technologies/Thermo Fisher, 308 
Waltham, MA, USA), using total RNA as the template.  The RT products were separated 309 
on a 7M urea-containing 5% polyacrylamide gel by electrophoresis.  The autoradiogram 310 
was scanned and recorded by a phosphoimager (GE Healthcare, Little Chalfont, 311 
Buckinghamshire, UK).  312 
 313 
2.12. Development of the TaqMan RT-qPCR method to measure rRNA depurination as a 314 
result of Stx2 cytotoxicity in HT29 cells   315 
  316 
 Based on the nucleotide sequence of human 28S rRNA (accession # NR_003287), 317 
and using the PrimerExpress software of Applied Biosystems (Life Technologies/Thermo 318 
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Fisher, Waltham, MA, USA), one set of primers (HSRL F and HSRL R) was designed to 319 
amplify the 71-bp spanning the depurination site at the 3’ end.  Two TaqMan probes 320 
(HSRL and HSRLm) were designed at the adenine depurination site to quantitate the 321 
non-depurinated and depurinated 28S rRNA levels in HT29 cells, taking advantage of the 322 
T to A transversion (mutation).  Another set of primers and a TaqMan probe (H28S) were 323 
designed to amplify the 62-bp at the 5’ end of the 28S rRNA to measure the total 28S 324 
rRNA levels.  The oligonucleotide primers were synthesized by Sigma Aldrich (St. 325 
Louis, MO, USA).  The TaqMan probes were synthesized by Applied Biosystems (Life 326 
Technologies/Thermo Fisher, Waltham, MA, USA).  The positions of these primers and 327 
TaqMan probes are illustrated in Fig. 1 and the sequences are shown in Supplement 2.     328 
 Reverse transcription reaction was carried out with 10 ng of total RNA, using the 329 
High Capacity cDNA Kit (Life Technologies/Thermo Fisher, Waltham, MA, USA) and 330 
random primers.  The qPCR analysis was performed with the 2× TaqMan Master Mix 331 
(Life Technologies/Thermo Fisher, Waltham, MA, USA) and the designed primer and 332 
TaqMan probe sets with final concentrations of 900 nM for each primer and 250 nM for 333 
each probe in, totally, 10 l.  The reaction cycles were as follows: 95 oC, 20 min, 1 cycle; 334 
95 
o
C, 1 min, 60 
o
C, 2 min, 40 cycles.   335 
  336 
2.13. Treatment of HT29 cells with Stx2 and POS   337 
 338 
HT29 cells were seeded into a 24-well plate (Thermo Fisher, Waltham, MA, 339 
USA) and grown to 90% confluence.  Before treatment with POS and Stx2, cells were 340 
washed once with PBS buffer after aspirating the culturing medium.  POS with different 341 
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concentrations was incubated with 5 ng of Stx2 in 100 l volume of DMEM for 1 h at 342 
room temperature.  These “pre-culture (PC)” POS and Stx2 mixtures were added to HT29 343 
cells which were then incubated at 37 
o
C with 5% CO2 for 24 h.  Alternatively, POS at 344 
different concentrations was mixed with 5 ng of Stx2 in 100 l volume of DMEM and 345 
added directly to HT29 cells without pre-incubation, designated as “co-culture (CC)” 346 
samples.  Total RNA was isolated from treated HT29 cells using the RNeasy Mini Prep 347 
Kit (Qiagen, Hilden, Germany) and quantitated by a Nanodrop Spectrophotometer 348 
(Thermo Fisher, Waltham, MA, USA).   349 
 350 
2.14. Competition ELISA   351 
 352 
To understand the protective mechanism of POS on HT29 cells against Stx2, 353 
competition ELISA (enzyme-linked immunosorbent assay) was conducted to evaluate if 354 
POS1 could compete with Stx2 to bind to the Gb3 (globotriaosylceramide) receptor on 355 
the cells.  Gb3 was purchased from Matreya LLC. (State College, PA, USA), diluted in 356 
100% methanol, and added to each well of the 96-well plate (50 ng/well).  The plate was 357 
incubated at room temperature for 2 h until the methanol was evaporated.  The wells were 358 
blocked with 300 l of 5% dry milk prepared in PBS and incubated at 37 oC for 1 h.    359 
For pre-treatment of Stx2, POS1 at 0.02, 0.2 and 1 mg/ml was mixed with 5 ng of Stx2 360 
and incubated at 37 
o
C for 1 h.  Otherwise, POS1 at these concentrations was mixed with 361 
5 ng of Stx2 and added directly to each well in 100 l of PBS, followed by incubation at 362 
37 
o
C for 1 h.  Polyclonal antibody, specific to the Stx B-subunit, was obtained from BEI 363 
Resource, diluted to 1.3 g/ml with 5% dry milk in PBS, and added to the wells (80 364 
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l/well), followed by incubation at 37 oC for 1 h.  Mouse monoclonal antibody against 365 
rabbit IgG, coupled with alkaline phosphatase (Sigma Aldrich, St. Louis, MO, USA), was 366 
diluted by 1:1000 in 5% dry milk/PBS and added to the wells (50 l/well).  The plate was 367 
incubated at 37 
o
C for 1 h.  Lastly, the SIGMAFAST p-nitrophenyl phosphate tablet 368 
(Sigma Aldrich, St. Louis, MO, USA) was dissolved in SIGMAFAST Tris Buffer (Sigma 369 
Aldrich, St. Louis, MO, USA) and added to the wells (50 l/well).  The plate was 370 
incubated at room temperature until the yellow colour became apparent and read at 405 371 
nm with the Synergy 4 plate reader (BioTek, Winooski, VT, USA).      372 
 373 
3. Results and discussion 374 
 375 
3.1. POSs  376 
 377 
 Galacturonic acid was the major saccharide residue in four of the pectic fractions 378 
(POS1, POS2, MCP1 and MCP2), ranging from 49.2% (w/w) to 79.0% (Table 1).  The 379 
galacturonic acid content of OpPOS was 22.8%, which meant it was enriched in RG I 380 
compared to the other pectic fractions that had 2-3.5× more homogalacturonan, based on 381 
galacturonic acid:rhamnose ratios (Table 1).  Significant arabino-oligosaccharide 382 
branches were present in the OpPOS and POS2 RG I while the galacto-oligosaccharide 383 
branches were similar for all samples, based on monosaccharide ratios (Table 1).  POS2 384 
reproduced the OpPOS fraction structure published previously (Manderson, et al., 2005) 385 
in which the rhamnogalacturonan is heavily substituted with arabinan and 386 
arabinogalactan.  Arabino- and galacto-oligosaccharide structures are important for the 387 
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prebiotic properties of POS (Onumpai, Kolida, Bonnin, & Rastall, 2011).  MCP contains 388 
unsaturated oligogalacturonic acids as well as rhamnogalacturonan II produced by 389 
enzymatic hydrolysis of commercial pectin to provide anti-cancer, immuno-stimulatory 390 
and heavy metal-binding properties (Eliaz, Hotchkiss, Fishman, & Rode, 2006; Maxwell, 391 
Colquhoun, Chau, Hotchkiss, Waldron, Morris, et al., 2015; Ramachandran, Wilk, 392 
Hotchkiss, Chau, Eliaz, & Melnick, 2011).  Unsaturated oligogalacturonic acids with a 393 
DP of 2-7 were the intermediate degradation products of citrus pectin during human 394 
faecal bacterial fermentation (Dongowski & Lorenz, 1998).  The degree of methyl 395 
esterification was low in MCP1 and MCP2 (5.3% and 3.3%), intermediate in POS1 and 396 
POS2 (40.1% and 42%), and high in OpPOS (66.3%) (Table 1).  MCP1 had the lowest 397 
MW (9.2 × 10
3
) and MCP2 had the second lowest MW (17.1 × 10
3
), followed by POS1, 398 
OpPOS and POS2 (811 x 10
3
) (Table 1).  However, the OpPOS and POS2 weight average 399 
molar masses were likely higher than their molecular weights reported in Table 1, due to 400 
a high light-scattering signal that eluted earlier than the refractive index signal in the 401 
HPSEC chromatograms (data not shown).  This typically indicates aggregation of smaller 402 
pectic components that may not be covalently linked together as has been reported 403 
previously for pectin (Fishman, Chau, Cooke, & Hotchkiss, 2008).   404 
  405 
3.2. SCFA production 406 
 407 
 The average SCFA produced from mixed batch fermentation, using faeces from 408 
five donors, is shown in Table 2.  Total organic acids increased sharply by 10 h, reaching 409 
a maximum after 36-48 h for POS1, POS2, MCP1 and inulin.  Acetate, propionate and 410 
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butyrate concentrations increased with fermentation time until 48 h.  Lactate and formate 411 
are fermentation intermediates and they completely disappeared after 24 h. Acetate was 412 
previously reported as the main SCFA from pectin oligosaccharide fermentation, 413 
followed by propionate and butyrate (Dongowski & Lorenz, 1998; Titgemeyer, Bourquin, 414 
Fahey, & Garleb, 1991).  Butyrate levels were significantly higher with inulin compared 415 
to the other substrates at 24 h, and inulin produced more butyrate than POS1 and MCP1 416 
at 36 h. High standard deviation values made it impossible to distinguish between 417 
butyrate levels produced by all substrates at 48 h and other times during fermentation.  418 
Butyrate is considered to be important for colonic health and function (Hamer, Jonkers, 419 
Venema, Vanhoutvin, Troost, & Brummer, 2008). All pectic substrates evaluated 420 
consistently produced butyrate and it is anticipated that they would promote colonic 421 
health.  Overall, POS1, POS 2 and MCP1 showed similar fermentabilities to inulin, based 422 
on the average total organic acids, acetate, propionate, lactate and formate concentrations.  423 
OpPOS had a fermentability similar to fructo-oligosaccharides, producing acetate, 424 
butyrate, lactate and propionate in that concentration order for 24 h of human faecal 425 
fermentation (Manderson, et al., 2005).  The degree of methyl esterification, sugar 426 
composition and molecular weight did not influence the POS or MCP fermentability, as 427 
reflected by the similar SCFA yield and profile.   428 
 429 
3.3. Microbiota changes  430 
 431 
The microbial profiles in the batch cultures are presented in Table 3.  Inulin, 432 
POS1, POS2 and MCP1 significantly increased Bif164 numbers, with numbers remaining 433 
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elevated at 48 h (36 h for POS1) compared to time 0.  Inulin and POS2 were significantly 434 
more bifidogenic than were POS1 and MCP1 throughout the fermentation period.  After 435 
24 h of fermentation, inulin was more bifidogenic than was POS2. The bifidogenic 436 
properties of OpPOS were similar to fructo-oligosaccharides, as reported previously 437 
(Manderson, et al., 2005).  A rise in Lab158 level was obtained with POS2 through 48 h, 438 
inulin through 36 h and POS1 through 24 h of fermentation.   439 
Our results confirm the previously reported correlation between arabinose content 440 
and bifidogenic properties (Manderson, et al., 2005; Onumpai, Kolida, Bonnin, & Rastall, 441 
2011) since POS2 and OpPOS exerted higher stimulation of Bif164 than did POS1 and 442 
MCP.  The pectic oligosaccharide MW and DE did not affect their bifidogenic properties 443 
since POS1 and MCP1 were equally bifidogenic.  However, all pectic substrates 444 
evaluated were bifidogenic.  Therefore, structural diversity in pectic prebiotics is possible 445 
as long as significant arabino- and galacto-oligosaccharide content is present.  446 
Bifidogenic POS activity was the only prebiotic property previously reported (Manderson, 447 
et al., 2005; Onumpai, Kolida, Bonnin, & Rastall, 2011) and this is the first report of POS 448 
selecting for higher lactobacillus levels during mixed batch faecal fermentation.    449 
Erec482 levels increased with MCP1 through 36 h and with inulin at 24 h (Table 450 
3).   OpPOS was previously reported to enhance Erec482 counts and butyrate production 451 
during human faecal fermentation and Eubacterium rectale is known to produce butyrate 452 
(Manderson, et al., 2005).  In our analysis, MCP1 Erec482 numbers did not correlate with 453 
butyrate concentration, since MCP1 produced less butyrate than inulin did.  In other 454 
treatments, Erec482 counts remained at the inocula levels.  MCP1 might increase non-455 
butyrate producing-bacteria detected by the Erec482 probe and increases in butyrate 456 
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levels produced by other substrates may be due to faecal bacteria besides Eubacterium 457 
rectale. 458 
The significant increase in Bac303 numbers on all substrates through 48 h of 459 
fermentation (Table 3) agreed well with data published previously (Onumpai, Kolida, 460 
Bonnin, & Rastall, 2011).  Bacteroides have the ability to utilize pectin and many 461 
bacteroides strains isolated from human faeces can produce various pectinolytic enzymes, 462 
including polygalacturonase, pectin methylesterase, extracellular and cell-associated 463 
pectate lyase (Bayliss & Houston, 1984; Dekker & Palmer, 1981; Jensen & Canale-464 
Parola, 1986).  Chis150 numbers rose on MCP1 through 36 h, POS2 through 24 h and 465 
inulin at 10 h.  Bac303 and Chis150 groups include pathogens. In a previous in vitro 466 
study of POS (Manderson, et al., 2005; Olano-Martin, Williams, Gibson, & Rastall, 467 
2003), Chis150 and Bac303 numbers remained at the initial level while Bif164 counts 468 
significantly increased.  The different results might be explained partly by carbohydrate 469 
structural differences or microbial variation in faecal samples.   470 
Ato291 levels increased with MCP1 and inulin through 48 h, POS2 through 36 h 471 
and POS1 at 48 h.  Atopobium is grouped within the actinomycetes, which can produce 472 
lactic acid (Jovita, Collins, Sjoden, & Falsen, 1999); it is one of the predominant bacterial 473 
groups in adult faeces (Harmsen, Wildeboer-Veloo, Grijpstra, Knol, Degener, & Welling, 474 
2000), and has been observed in a human trial of very long chain inulin from globe 475 
artichoke (DP 50-103) (Costabile, Kolida, Klinder, Gietl, Bauerlein, Frohberg, et al., 476 
2010).  However, the role of this bacterium in human gut health is not yet established.  477 
The total bacterial concentrations of the samples obtained from the pH-478 
temperature controlled stirred-batch fermentation, using POS1, POS2, MCP1 and inulin 479 
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as carbon sources, were measured by DAPI staining.  The data supported our findings 480 
shown in Table 3 and are presented in Supplement 1. 481 
 482 
3.4. Anti-bacterial adhesion activity of POS in HT29 cells 483 
 484 
We previously showed that OpPOS inhibited the adhesion of enteropathogenic E. 485 
coli and verotoxigenic E. coli strains to HT29 cells, by 50%, at a concentration of 0.15 to 486 
0.46 mg/ml (Rhoades, et al., 2008).  In this study, we showed that five pectic 487 
oligosaccharides (POS1, POS2, OpPOS, MCP1 and MCP2) displayed anti-adhesion 488 
activity to some degree against the Shiga toxin-producing E. coli O157:H7 in HT29 cells.  489 
Our results confirmed the previously reported correlation between oligogalacturonic acid 490 
content and inhibition of E. coli adhesion (Guggenbichler, De Bettignies-Dutz, Meissner, 491 
Schellmoser, & Jurenitsch, 1997) since POS1 had the highest anti-adhesion activity 492 
throughout the 0.005 – 5 mg/ml concentration range (Table 4) and it had a high 493 
GalA:Rha ratio (Table 1).  MCP1 and MCP2 also had high GalA:Rha ratios and 494 
exhibited anti-adhesion activity equivalent to POS1 in the 0.8-2.5 mg/ml concentration 495 
range.  These pectic substrates had similar monosaccharide compositions, lowest 496 
molecular weights and low degree of esterification with the exception of POS1, which 497 
had intermediate degree of esterification, indicating that smaller, deesterified structures 498 
are important for anti-adhesion activity.  OpPOS had the lowest GalA:Rha ratio of the 499 
pectic substrates but minor amounts of unsaturated oligogalacturonic acids present in this 500 
sample may have contributed to its anti-adhesion activity in the lower oligosaccharide 501 
concentration range (0.005 - 0.5 mg/ml) where the greatest anti-adhesion activity (50 - 90% 502 
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inhibition of E. coli O157:H7 adhesion) was observed.  The relatively high degree of 503 
esterification in OpPOS limited its anti-adhesive activity at 0.5 mg/ml and higher 504 
concentrations.   505 
The adhesion of E. coli STEC strains to human cells involves multiple 506 
mechanisms, including intimin (McKee, Melton-Celsa, Moxley, Francis, & O'Brien, 507 
1995), E. coli common pilus (Rendon, Saldana, Erdem, Monteiro-Neto, Vazquez, Kaper, 508 
et al., 2007) and type IV pilus (Xicohtencatl-Cortes, Monteiro-Neto, Ledesma, Jordan, 509 
Francetic, Kaper, et al., 2007).  High E. coli O157:H7 anti-adhesion activity, correlated 510 
with the lower range of oligosaccharide concentrations, has been reported previously for 511 
OpPOS (Rhoades, et al., 2008) and cranberry xyloglucan (Hotchkiss, et al., 2015).  We 512 
recently reported that cranberry xyloglucan oligosaccharides were inhibitory to the 513 
adhesion of an STEC strain ATCCBAA-1883 on HT29 cells at low concentrations 514 
(0.001-0.1 mg/ml) (Hotchkiss, et al., 2015).  However, xyloglucan oligosaccharides had 515 
much higher affinity for type 1 fimbriated uroepithelial E. coli that are specifically 516 
inhibited by mannose-containing oligosaccharides (Hotchkiss, et al., 2015).  Pectin-like 517 
acidic polysaccharide from the root of Panax ginseng, which consists primarily of 518 
galacturonic and glucuronic acids along with rhamnose, arabinose, and galactose as 519 
minor components, exerted a selective anti-adhesive effect against pathogenic bacteria 520 
Actinobacillus actinomycetemcomitans, Propionibacterium acnes and Staphylococcus 521 
aureus while having no effects on beneficial and commensal bacteria Lactobacillus 522 
acidophilus, Escherichia coli or Staphylococcus epidermidis (Lee, Shim, Lee, Kim, 523 
Chung, & Kim, 2006).  Our results with POS1, POS2, MCP1, and MCP2 confirmed 524 
other reports (Olano-Martin, Williams, Gibson, & Rastall, 2003; Rhoades, et al., 2008) 525 
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that pectic oligosaccharides block the specific interaction required for adhesion of P-526 
fimbriated E. coli to human epithelial cells.  It is known that P-fimbriated E. coli and 527 
Stxs, produced by STEC, utilize the same α-Gal-(1-4)-β-Gal terminal oligosaccharide 528 
receptor to adhere to epithelial cells.  The mechanism of POS inhibition of P-fimbriated 529 
E. coli adhesion remains unknown, since α-Gal-(1-4)-β-Gal was not observed in the 530 
structures of our POSs, and receptor mimicry is unlikely to be involved. 531 
 532 
3.5. rRNA depurination by Stx2 was measured by the novel TaqMan RT-qPCR method   533 
 534 
To investigate whether the anti-E. coli O157:H7 adhesion activity of orange POSs 535 
in HT29 cells could result in reduction of Stx cytotoxicity, we first developed a TaqMan 536 
probe-based RT-qPCR analysis to measure the rRNA depurination caused by pure Stx2 537 
holotoxin.  Due to the specific removal of a single adenine (depurination) from the SRL 538 
of the large subunit of rRNA by Stx, we took advantage of the creation of the T → A 539 
transversion when cDNA is synthesized by reverse transcriptase, using depurinated 540 
rRNA as the template, and designed two TaqMan probes.  The first was the SRL probe 541 
(T1) that could measure the level of un-depurinated, intact rRNA when paired with 542 
depurination forward (Dep F, P5) and depurination reverse (Dep R, P6) primers (Fig. 1a 543 
and Supplement 2).  The second TaqMan probe was the SRLm probe (T3) that could 544 
measure the depurinated rRNA level when paired with Dep F and Dep R primers (Fig. 1a 545 
and Supplement 2).   546 
After HT29 cells were treated with pure Stx2 holotoxin (50 ng/ml) for 24 h, total 547 
RNA was isolated and cDNA was produced by reverse transcriptase, using random 548 
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primers.  Stx2 at 50 ng/ml has been shown to cause rRNA depurination of Vero cells 549 
(Pang, et al., 2011); we used the established dual primer extension method to determine 550 
whether Stx2-treated HT29 cells were depurinated under the experimental conditions.  As 551 
shown in Fig. 1b, the Stx2-treated HT29 cells produced the predicted depurination band 552 
of 72 bases by the P2 (Dep) primer as well as the control band of 99 bases by the P1 (28S) 553 
primer, compared to the untreated cells that produced only the control 28S band.    554 
To measure rRNA depurination caused by Stx2 in HT29 cells by our novel 555 
TaqMan probe-based RT-qPCR method, the amplification efficiencies of Dep F (P5)/Dep 556 
R (P6) primers and SRL (T2), SRLm (T3) TaqMan probes for non-depurinated and 557 
depurinated rRNA, and 28S F (P3)/28S R (P4)/28S probe (T1) for total 28S rRNA, were 558 
first validated.  The cDNAs from the untreated and Stx2-treated cells were serial-diluted.  559 
The cDNA serial dilutions from the untreated cells were amplified by Dep F/Dep R and 560 
the SRL probe, and the cDNA serial dilutions from the Stx2-treated cells were amplified 561 
by Dep F/Dep R and the SRLm probe.  Additionally, the cDNA serial dilutions from the 562 
untreated cells were amplified by the 28S F/28S R/28S probe.  Fig. 1c shows that the 563 
intercept and R
2 
value were -3.476 and 0.9995 for Dep F/Dep R/SRL, -3.46 and 0.9981 564 
for Dep F/Dep R/SRLm, and -3.652 and 0.9988 for 28S rRNA (as the endogenous 565 
control), indicating that the non-depurinated rRNA, depurinated rRNA and total 28S 566 
rRNA were equally efficiently amplified by our designed primers and TaqMan probes. 567 
The 1:100-diluted cDNA samples from the Stx2-treated and untreated (control, 568 
Ctr) HT29 cells were amplified by the primers/TaqMan probe sets for the three gene 569 
targets, SRLm (representing the depurinated rRNA), SRL (representing the non-570 
depurinated rRNA) and 28S (representing the total rRNA).  The average threshold cycle 571 
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(Ct) numbers from triplicates were used to calculate the fold-change of SRLm and SRL 572 
levels in Stx2-treated HT29 cells (Stx2 sample) compared to the untreated (Ctr sample), 573 
relative to the level of 28S (Supplement 3).  Because not all of the rRNA molecules are 574 
depurinated by Stx2, the ratio of the SRLm level over that of SRL would represent the 575 
level of rRNA depurination.  A higher ratio of SRLm/SRL indicates a higher level of 576 
rRNA depurination in the cells.   Supplement 3 shows that the ratio of SRLm/SRL in the 577 
Stx2-treated cells was 39.7.  578 
Following ingestion of STEC, the bacterial cells colonize human intestines and 579 
produce Stxs, which then interact with glycolipid Gb3 receptor and become internalized 580 
into the intestinal epithelial cells (Hurley, Jacewicz, Thorpe, Lincicome, King, Keusch, et 581 
al., 1999).  Therefore, prebiotics, food constituents or inhibitors that can prevent the 582 
colonization and the Stx internalization will be of great advantage to prevent the 583 
detrimental effects of STEC and Stxs.  Our results showed that the primer/TaqMan probe 584 
sets that we designed for the SRLm, SRL and 28S gene targets were able to sensitively 585 
quantify the levels of rRNA depurination caused by Stx2 in HT29 cells (Fig. 1a and 586 
Supplement 3).    587 
 588 
3.6. Orange POSs reduced the Stx2 rRNA depurination in HT29 cells   589 
 590 
HT29 cells have been shown to be intoxicated by pure Stx holotoxins (Olano-591 
Martin, Williams, Gibson, & Rastall, 2003; Rhoades, et al., 2008).   To determine if 592 
orange POSs could directly interact with Stx2 and inhibit its internalization into cells, we 593 
incubated orange POSs with Stx2 and then measured the reduction of rRNA depurination 594 
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in HT29 cells.  For this testing, we selected POS1 and MCP2 for the best performance in 595 
the anti-bacterial adhesion assay; we also selected OpPOS as the acid preparation of 596 
orange POS, and we selected POS2 as the one with the lowest anti-bacterial adhesion 597 
activity (Table 4).  For the “pre-culture (PC)”samples, POS1, MCP2, OpPOS and POS2, 598 
at different concentrations, were incubated with 5 ng of Stx2 for 1 h at room temperature 599 
before being added to HT29 cells.  For the “co-culture (CC)” samples, these four orange 600 
POSs were mixed with 5 ng of Stx2 and added directly to HT29 cells.  The addition of 601 
POSs alone to HT29 cells did not cause cell death, as measured by the MTS assay 602 
(Promega, Madison, WI) (data not shown). 603 
 After 24 h of treatment, HT29 cells were lysed; total RNAs were isolated, RT- 604 
and qPCR reactions were performed with the primer/TaqMan sets for SRLm, SRL and 605 
28S gene targets (Supplement 2).  The ratios of SRLm/SRL were calculated, as 606 
mentioned above, and compared to that of the Stx2-treated cells.  Our results showed that 607 
all four POSs reduced the Stx2 rRNA depurination when co-cultured with Stx2 in HT29 608 
cells (Table 5).  The best performer in anti-adhesion assay, POS1, displayed the highest 609 
reduction in the Stx2 rRNA depurination in a dose-dependent manner.  More than 44% 610 
reduction of rRNA depurination was achieved when POS1 at 100 g/ml concentration 611 
was co-cultured with Stx2.  POS1 was also the only one that could reduce Stx2 rRNA 612 
depurination when pre-incubated with Stx2 at concentration of 10 and 100 g/ml; 613 
however, at much lower levels, 3.43% and 6.59%, respectively.   614 
 615 
3.7. Orange POS1 competed with Stx2 to bind to Gb3 on HT29 cells   616 
 617 
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 The pentamer of StxB subunits binds to the glycolipid globotriaosylceramide 618 
(Gb3) receptor on the human cell surface to get StxA subunit internalized (Di, Kyu, 619 
Shete, Saidasan, Kahn, & Tumer, 2011; Jacewicz, Clausen, Nudelman, Donohue-Rolfe, 620 
& Keusch, 1986).  Our results, above, demonstrated that all four POSs reduced the Stx2 621 
depurination of HT29 rRNA when co-cultured with Stx2, suggesting that POSs might 622 
compete with Stx2 for binding sites on the HT29 cell surface, thus blocking the entry of 623 
Stx2A into cells.  We devised a competition ELISA assay to test whether POS1 could 624 
compete with Stx2 to bind to Gb3.  Our data showed that, when POS1 was co-incubated 625 
with Stx2, it reduced the interaction of Stx2 with Gb3 coated in the wells of the 96-well 626 
plate.  This reduction was also dose-dependent for POS1.  An average of 22.1%, 29.2% 627 
and 38.2% reduction was achieved with POS1 at 0.02, 0.2 and 1 mg/ml, respectively.  628 
POS1 could also reduce the interaction between Stx2 and Gb3 dose-dependently after 629 
pre-incubation with Stx2 at room temperature for 1 h, although at lower levels 630 
(Supplement 4).   This result suggests that POS1 could not only compete with the Stx2 B-631 
subunit to bind to Gb3; it might also damage Stx2 in some way to reduce its cytotoxicity. 632 
 633 
4. Conclusion 634 
 635 
The utilization of oligosaccharides derived from agricultural by-products to 636 
selectively stimulate the growth of beneficial bacteria and inhibit bacterial attachment of 637 
pathogens has proven successful for a number of pectic oligosaccharide in vitro.  Our 638 
investigation suggests that different pectic oligosaccharide compositions, based on the 639 
extraction method, origin, molecular weight and degree of esterification, exhibit 640 
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consistent in vitro prebiotic activity.  This investigation reaffirmed two bioactivity 641 
structure-function relationships that arabinose-rich rhamnogalacturonic acids are 642 
responsible for in vitro prebiotic activity and oligogalacturonic acids are responsible for 643 
STEC anti-adhesion activity.  Our results report, for the first time, that pectic 644 
oligosaccharides select for lactobacilli, as well as bifidobacteria, and that low molecular 645 
weight deesterified structures enhance STEC anti-adhesive activity.  Before any claims 646 
for POSs to be functional food ingredients can be made, more study is needed and their 647 
efficacy in human volunteer trials must also be established.  These oligosaccharides have 648 
the potential, in the near future, to join the arsenal of drugs for the therapy of bacterial 649 
diseases and health-promoting bioactive food ingredients.  650 
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Figure legend 802 
 803 
Fig. 1. (a) Primer and TaqMan probe locations in human 28S rRNA (GenBank accession 804 
# NR_003287) for dual primer extension and RT-qPCR amplification.  Refer to 805 
Supplement 2 for primer (P) and TaqMan (T) probe numbers, names and sequences.  (b) 806 
Dual primer extension assay to measure 28S rRNA depurination by Stx2 in HT29 cells.  807 
Stx2, Stx2-treated HT29 cells; Ctr, untreated cells.  (c) Development of the novel 808 
TaqMan-based RT-qPCR analysis for 28S rRNA depurination measurement.  The 809 
primers and TaqMan probes designed for the SRL, SRLm and 28S gene targets were 810 
validated by analyzing the 10-fold dilutions of the RT product of Stx2-treated HT29 cells 811 
in RT-qPCR reactions.  The standard curves of these three gene target amplifications are 812 
shown with the amplification equations and R
2 
values. 813 
 814 
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Table 1 1 
Chemical characterization of orange pectic oligosaccharides.  2 
________________________________________________________________________ 3 
Orange POS  POS1         POS2    MCP1          MCP2        OpPOS 4 
________________________________________________________________________ 5 
Molecular weight  6 
(MW ×10
3
)  72.8         811    9.2             17.7         140.3 7 
 8 
Monosaccharide (mole %) 9 
Glucose  2.07         3.76    2.17             2.26         5.77 10 
Arabinose  3.24         33.7    3.28             4.76         44.2 11 
Galactose  11.6         6.85    10.3            19.2        20.2 12 
Xylose   1.01         2.04     1.45             1.17         2.69 13 
Rhamnose  3.69         3.47    3.53             4.29         3.56 14 
Fucose   0.12         0.31    0.13             0.24         0.23 15 
Glucuronic acid 0.28         0.66    0.11             0.16          0.46 16 
Galacturonic acid 78.0         49.2    79.0            68.0        22.8   17 
 18 
GalA:Rha  21.1         14.2    22.4               15.8        6.42 19 
Ara:Rha  0.88          9.71    0.93                1.11          12.4 20 
Gal:Rha   3.14          1.97    2.92                4.47          5.68 21 
 22 
Average % degree   40.1±        42.0±    5.3±             3.3±         66.3± 23 
of esterification 0.88        0.61    0.52             0.14         0.2 24 
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Table 2  26 
Concentration of organic acids in the fermentation samples obtained from the pH- and temperature-controlled stirred-batch fermentations, using 27 
POS 1, POS 2, MCP1 and inulin as carbon sources. 28 
 29 
Time  Acetate Propionate 
POS 1 POS 2 MCP1 Inulin POS 1 POS 2 MCP1 Inulin 
0h 2.41.3 1.91.3 2.41.7 1.61.9 00.1 00.1 0.10.1 0.30.4 
10h 48.128.6 50.118.3 52.015.6 49.615.9 7.73.8 9.93.6 8.22.0 10.09.0 
24h 62.218.4 71.417.9 68.49.9 68.719.1 10.52.2 15.14.1 11.61.8 20.412.1 
36h 68.115.7 76.718.4 77.812.9 73.120.9 12.12.1 16.93.8 13.44.3 24.618.1 
48h 68.818.0 83.622.8 82.014.5 68.720.5 12.61.9 18.75.0 14.94.4 22.315.8 
Time  Lactate Formate 
POS 1 POS 2 MCP1 Inulin POS 1 POS 2 MCP1 Inulin 
0h 0.50.5 2.02.0 0.50.5 0.40.6 3.20.8 7.20.8 2.80.5 0.20.5 
10h 3.22.1 3.44.4 3.22.5 6.15.0 5.35.5 6.16.3 5.93.6 2.52.9 
  
4 
 
24h 0.0 6.31.9 0.80.4 0.0 0.0 0.0 0.0 0.0 
36h 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
48h 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
Time  Butyrate Total organic acids 
POS 1 POS 2 MCP1 Inulin POS 1 POS 2 MCP1 Inulin 
0h 0.10.1 0.00.1 0.10.1 0.30.4 5.72.9 4.92.4 5.82.4 4.62.6 
10h 2.23.1 3.52.9 3.63.1 5.85.7 66.637.7 73.026.5 72.920.5 74.020.2 
24h 5.33.3b 6.24.9b 4.43.0b 11.94.4a 78.024.2 94.016.0 84.57.3 10116.5 
36h 6.23.9b 8.34.9ab 5.52.4b 12.43.1a 86.519.7 10224.0 96.713.7 11026.7 
48h 7.04.0 10.66.4 6.53.1 12.92.8 88.421.6 11330.6 10316.5 10324.1 
 30 
All numbers are means of five samples ±SD, expressed as mmol/ml.  Alphabetical superscript: significantly different among treatments 31 
at the same time point.  Values in the same row not sharing the same superscript are significantly different (P0.05). 32 
  33 
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Table 3  34 
Bacterial concentrations of the samples obtained from the pH- and temperature-controlled stirred-batch fermentations using POS 1, POS 35 
2, MCP1 and inulin as carbon sources (Bif164: Bifidobacterium, Erec 482: Eubacterium rectale/Clostridium coccoides, Lab158: 36 
Lactobacillus/Enterococcus, Bac303: Bacteroides/Prevotella, Ato291: Atopobium cluster, Chis150: Clostridium histolyticum). 37 
Time  
 
Bif164 Erec482 
POS 1 POS 2 MCP1 Inulin POS 1 POS 2 MCP1 Inulin 
0h 7.83±0.24 7.81±0.13 7.780.19 7.700.28 8.050.11 8.050.10 8.020.18 8.080.17 
10h 8.110.19b* 8.670.16a* 8.240.27b* 8.660.24a* 8.300.34 8.230.33 8.240.26* 8.230.31 
24h 8.100.16b* 8.680.17a* 8.180.12b* 8.820.29a* 8.200.27 8.300.30 8.340.13* 8.310.17* 
36h 8.130.19c* 8.710.11b* 8.130.13c* 9.010.30a* 8.150.19 8.180.34 8.340.12* 8.220.15 
48h 8.030.6c 8.670.16b* 8.210.17c* 9.090.16a* 8.030.15 8.080.31 8.310.17 8.020.20 
Time  
Lab158 Bac303 
POS 1 POS 2 MCP1 Inulin POS 1 POS 2 MCP1 Inulin 
0h 6.400.19 6.400.23 6.500.19 6.440.15 8.040.22 7.960.24 8.090.26 7.980.31 
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10h 6.580.26* 6.900.20* 6.940.37 6.820.35* 8.690.43* 8.800.21* 8.850.40* 8.620.46* 
24h 6.620.25b* 7.260.28a* 7.040.54ab 7.280.60a* 9.050.35* 9.080.33* 9.040.23* 9.050.24* 
36h 6.550.54b 7.110.57a* 6.790.45ab 7.030.51a* 8.820.35ab* 8.890.15ab* 8.900.24a* 8.880.26ab* 
48h 6.410.38b 6.960.35a* 6.640.41b 7.060.64a 8.690.28* 8.790.18* 8.670.32* 8.650.38* 
Time  
Ato291 Chis150 
POS 1 POS 2 MCP1 Inulin POS 1 POS 2 MCP1 Inulin 
0h 7.46±0.17 7.43±0.19 7.48±0.16 7.57±0.18 6.07±0.34 6.09±0.39 6.09±0.30 6.07±0.22 
10h 7.99±0.60 7.83±0.20
*
 8.21±0.44
*
 8.30±0.27
*
 6.31±0.40
b
 6.85±0.30
a*
 6.48±0.19
b*
 6.35±0.17
b*
 
24h 8.00±0.54 7.95±0.32
*
 8.32±0.57
*
 8.37±0.42
* 
6.46±0.38 6.68±0.27
*
 6.44±0.32
*
 6.41±0.34 
36h 8.10±0.49 7.98±0.32
*
 8.36±0.60
*
 8.33±0.34
*
 6.11±0.24
b
 6.40±0.38
ab
 6.61±0.47
a*
 6.10±0.29
b
 
48h 8.05±0.38
*
 7.71±0.39 8.27±0.59
*
 8.15±0.26
*
 5.87±0.38 6.16±0.41 6.14±0.54 6.06±0.38 
 38 
All numbers are means of five samplesSD expressed as Log10cells/ml.  39 
*
: significant increase from 0h; Alphabetical superscript: significantly different among treatments at the same time point.  40 
Values in the same row not sharing the same superscript are significantly different (P0.05). 41 
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Table 4  
Anti-adhesion activity of POS samples at different concentrations against E. coli O157:H7 strain 
ATCC43895 compared to untreated control sample. 
Adhesion Relative to Control (%) 
mg/mL POS1 POS2 OpPOS MCP1 MCP2 
0.001 32.9±2.0
a1
 68.02±2
a3 
       30.9±1.2
a1
      39.6±1.4
a2
 39.1±1.4
a2
 
0.005 13.7±1.5
b1
 47.1±1.5
b3  
   8.6±0.6
b1
      39.1±0.7
a2
     35.0±0.7
a2
 
0.01 17.4±2.3
b1
 51.5±3
b3
        15.8±0.5
c1
      40.0±1.4
a2
      38.8±7.8
a2
 
0.05 26.0±0.6
c1
 77.6±2
c3 
       20.9±1
c1
        47.8±4.2
b2
      40.8±5.7
a2
 
0.1 33.3±0.3
c1
 79.0±0.6
c3   
 34.5±1.5
ad1
    51.8±2.8
b2
      44.1±7.1
a2
 
0.5 40.2±0.3
d1
 94.8±0.2
d4
    83.5±1.4
e3
   55.1±0.7
b2 
     52.0±2.8
b2
 
0.8 51.1±0
e2
 98.8±0.2
d4
     93.5±2
f4 
     61.6±2.8
c3
     37.0±0
a1
 
1 56.6±0.2
e1
 100±0.4
d2 
    97.1±1
f2
        57.3±1.8
bc1
     57.0±1.1
b1
 
2.5 74.0±2
f2
 100±0.8
d3  
   100±0.3
f3   
 63.5±2.8
c1
    77.1±1.3
c2
 
5 91.3±1
g1  
      100±0.4
d2
 100±1.8
f2 
  100±0
d2  
   100±0
d2
 
 
a,b,c,bc,d,e,f,g 
indicate significant differences in inhibition of E. coli O157:H7 ATCC43895 adhesion 
relative to the control at different concentrations of  the respective samples. 
1,2,3,4 
indicate 
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significant difference in anti-adhesive activity across all the oligosaccharides at one particular 
concentration based on ANOVA statistical analysis (P<0.05).  All values are the means ± 
standard deviation of results obtained with triplicates. 
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Table 5  
Reduction of Stx2 depurination activity by citrus pectic oligosaccharides in HT29 cells. 
________________________________________________________________________ 
        Average percentage reduction      
        of SRLm/SRL ratio 
Treatment       compared to Stx2-treated cells
*
  Standard Deviation
*
    
_______________________________________________________________________  
POS1 1 g/ml PC    0     0 
POS1 10 g/ml PC   3.43     0.64 
POS1 100 g/ml PC   6.59     0.18 
POS1 1 g/ml CC             13.1     5.10 
POS1 10 g/ml CC            37.7     2.45  
POS1 100 g/ml CC            44.1     2.50 
 
MCP2 1 g/ml PC               0     0 
MCP2 10 g/ml PC   0     0 
MCP2 100 g/ml PC   0     0 
MCP2 1 g/ml CC    13.0     0.17 
MCP2 10 g/ml CC   25.8     0.40 
MCP2 100 g/ml CC     9.51     2.08 
 
POS2 1 g/ml PC    0     0 
POS2 10 g/ml PC   0     0 
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POS2 100 g/ml PC   0     0 
POS2 1 g/ml CC    0     0 
POS2 10 g/ml CC            20.8     5.03 
POS2 100 g/ml CC            24.2     3.74 
 
OpPOS 1 g/ml PC               0     0  
OpPOS 10 g/ml PC              0     0 
OpPOS 100 g/ml PC 0     0 
OpPOS 1 g/ml CC             27.9     1.59 
OpPOS 10 g/ml CC            32.6     4.43 
OpPOS 100 g/ml CC           31.3     6.32 
 
*
: The average percentage reduction and standard deviation were calculated from the SRLm/SRL 
ratios of each treatment sample compared to Stx2-treated cells in three independent experiments. 
  
Fig. 1 
5’ …………………………………. AGUACGAGAGGAACCG……………………. 3’ 
 
 
5’ …………………………………. AGTACGTGAGGAACCG……………………. 3’ 
 
 
 
5’ …………………………………. AGTACGTGAGGAACCG……………………. 3’ 
3’ ………………………....……….TCATGCACTCCTTGGC……………………. 5’ 
Normal 
28S rRNA 
RT on depurinated rRNA           T → A transversion 
Mutated 
ss cDNA 
qPCR 
Mutated 
ds cDNA 
P1 P2 
P3     T1 
P4 
P5 
P6 
T2/T3 
99 bases by P1 
72 bases by P2 
Stx2    Ctr   
a. 
b. 
c. 
SRL 
SRLm 
28S 
y = -3.476x + 22.77 
R² = 0.9995 
0
5
10
15
20
y = -3.46x + 22.795 
R² = 0.9981 
0
5
10
15
20
y = -3.652x + 20.82 
R² = 0.9988 
0
5
10
15
20
0.0001 0.001 0.01 0.1
cDNA dilution 
C
t 
C
t 
C
t 
  
Highlights 
 
 Bifidogenic citrus pectic oligosaccharide (POS) structural diversity was 
determined.  
 Five citrus pectic oligosaccharides were anti-adhesive for Shiga toxin (Stx)-
producing E. coli O157:H7 binding to human HT29 cells. 
 A novel TaqMan-based RT-qPCR assay was developed to measure the human 
rRNA depurination caused by Stx2. 
 Citrus POS samples reduce the cytotoxicity of Stx2 holotoxin in HT29 cells. 
